This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Glioblastoma
and you are
between 18 and 70
years old
0
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

This is an open-label positron emission tomography/near infrared (PET/NIRF) study to investigate the imaging navigation performance and evaluation efficacy of dual modality imaging probe 68Ga-BBN-IRDye800CW in glioblastoma (GBM) patients. A single dose of 40μg/111-148 Mega-Becquerel (MBq) and 1.0 mg/ml 68Ga-BBN-IRDye800CW will be injected intravenously before the operation and intraoperative respectively. Visual and semiquantitative method will be used to assess the PET images and real-time margins localization for surgical navigation.

Provided treatments

  • Drug: 68Ga-BBN-IRDye800CW
  • Device: PET/NIRF
  • Procedure: PET/NIR fluorescent imaging-guided surgery

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02910804. The sponsor of the trial is Beijing Tiantan Hospital and it is looking for 30 volunteers for the current phase.
Official trial title:
PET-NIRF Dual Modality Imaging Guiding Surgery in Patients With Glioblastoma